RSS
3 Jan 2022

Viking Therapeutics to Present at H.C. Wainwright BioConnect 2022 Conference

Author: admintech | Filed under: Press Release

SAN DIEGO, Jan. 3, 2022 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its chief executive officer, Brian Lian, Ph.D.,…

This entry was posted on Monday, January 3rd, 2022 at 7:34 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»